Omeros: The Trade After European Rejection
Omeros received European rejection for a therapy but holds exclusive U.S. FDA approval in its market segment.· summarised by Stockedin
SeekingAlphaRead at the source
OMER
Back to marketsAdd to watchlist Oct 28, 2025 · 7.96 USDOct 28, 2026 · 17.66 USD
Omeros Corporation
OMER · NasdaqGM
$17.66+0.94%(+0.17)
Yahoo Finance · delay unknown · USD · just in
Price history
Yahoo Finance · delay unknown · USD · 5 h old
Key figures
- Previous close
- 17.49
- Day range
- 17.25 – 17.67
- Volume
- 278.2K
- Market cap
- —
Information, not investment advice.
News about Omeros Corporation
Finnhub · delay unknown · 8 days old
Headline and publisher summary only; full articles stay with the source.